The Incidence and Risk Factors for Psoriatic Arthritis in Patients with Psoriasis: A Prospective Cohort Study

Arthritis and Rheumatology

Volumn 68, Issue 4, 2016, Pages 915-923

  Eder, Lihi ^a   Haddad, Amir ^a   Rosen, Cheryl F ^a   Lee, Ker Ai ^b   Chandran, Vinod ^a   Cook, Richard ^b   Gladman, Dafna D ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; RETINOID; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HABIT; HIGH SCHOOL GRADUATE; HUMAN; INCIDENCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONSET AGE; PATIENT EDUCATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SPONDYLITIS; UVEITIS; ARTHRITIS, PSORIATIC; EDUCATIONAL STATUS; LONGITUDINAL STUDY; MULTIVARIATE ANALYSIS; NAIL DISEASES; ONTARIO; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX;

ADULT; ARTHRITIS, PSORIATIC; COHORT STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NAIL DISEASES; ONTARIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PSORIASIS; RETINOIDS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UVEITIS;

EID: 84962130173     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39494     Document Type: Article

References (35)

1. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ., Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141: 1537-41.
2. Haroon M, Kirby B, FitzGerald O., High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis 2013; 72: 736-40.
3. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P., Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005; 64 Suppl 2: ii14-7.
4. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Maradit Kremers H., Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009; 61: 233-9.
5. Christophers E, Barker JN, Griffiths CE, Dauden E, Milligan G, Molta C, et al., The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol 2010; 24: 548-54.
6. Eder L, Chandran V, Shen H, Cook RJ, Shanmugarajah S, Rosen CF, et al., Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res (Hoboken) 2011; 63: 619-22.
7. National Institute for Health and Clinical Excellence (UK). Psoriasis: assessment and management. NICE guidelines CG153; October 2012. London: National Institute for Health and Clinical Excellence; 2012.
8. Richard MA, Barnetche T, Rouzaud M, Sevrain M, Villani AP, Aractingi S, et al., Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: systematic review and expert opinion. J Eur Acad Dermatol Venereol 2014; 28 Suppl 5: 3-12.
9. Langenbruch A, Radtke MA, Krensel M, Jacobi A, Reich K, Augustin M., Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. Br J Dermatol 2014; 171: 1123-8.
10. Yang Q, Qu L, Tian H, Hu Y, Peng J, Yu X, et al., Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol 2011; 25: 1409-14.
11. Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N, et al., Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) 2013; 52: 568-75.
12. Love TJ, Zhu Y, Zhang Y, Wall-Burns L, Ogdie A, Gelfand JM, et al., Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 2012; 71: 1273-7.
13. Li W, Han J, Qureshi AA., Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 2012; 71: 1267-72.
14. Eder L, Law T, Chandran V, Shanmugarajah S, Shen H, Rosen CF, et al., Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken) 2011; 63: 1091-7.
15. Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN., Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 2008; 67: 672-6.
16. Olivieri I, Padula A, D'Angelo S, Scarpa R., Role of trauma in psoriatic arthritis. J Rheumatol 2008; 35: 2085-7.
17. Tey HL, Ee HL, Tan AS, Theng TS, Wong SN, Khoo SW., Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol 2010; 37: 426-30.
18. Gladman DD, Schentag CT, Tom BD, Chandran V, Brockbank J, Rosen C, et al., Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009; 68: 497-501.
19. Fredriksson T, Pettersson U., Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
20. Maksymowych WP, Mallon C, Morrow S, Shojania K, Olszynski WP, Wong RL, et al., Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis 2009; 68: 948-53.
21. Fries JF, Spitz P, Kraines RG, Holman HR., Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
22. Ware JE Jr, Snow KK, Kosinski M, Gandek B., SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center; 1993.
23. Finlay AY, Khan GK., Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6.
24. Steinbrocker O, Traeger CH, Batterman RC., Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-62.
25. Creemers MC, Franssen MJ, van 't Hof MA, Gribnau FW, van de Putte LB, van Riel PL., Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005; 64: 127-9.
26. Ibrahim G, Waxman R, Helliwell PS., The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009; 61: 1373-8.
27. Alenius GM, Stenberg B, Stenlund H, Lundblad M, Dahlqvist SR., Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 2002; 29: 2577-82.
28. Mease PJ, Gladman DD, Helliwell P, Khraishi MM, Fuiman J, Bananis E, et al., Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2014; 71: 649-55.
29. McGonagle D, Tan AL, Benjamin M., The nail as a musculoskeletal appendage: implications for an improved understanding of the link between psoriasis and arthritis. Dermatology 2009; 218: 97-102.
30. Love TJ, Gudjonsson JE, Valdimarsson H, Gudbjornsson B., Psoriatic arthritis and onycholysis-results from the cross-sectional Reykjavik psoriatic arthritis study. J Rheumatol 2012; 39: 1441-4.
31. Sampaio-Barros PD, Pereira IA, Hernandez-Cuevas C, Berman A, Burgos-Vargas R, Gutierrez MA, et al., An analysis of 372 patients with anterior uveitis in a large Ibero-American cohort of spondyloarthritis: the RESPONDIA Group. Clin Exp Rheumatol 2013; 31: 484-9.
32. Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT., Characterisation of uveitis in patients with psoriatic arthritis. Ann Rheum Dis 2000; 59: 67-70.
33. Fraga NA, Oliveira MF, Follador I, Rocha BO, Rego VR., Psoriasis and uveitis: a literature review. An Bras Dermatol 2012; 87: 877-83.
34. Ward MM, Reveille JD, Learch TJ, Davis JC Jr, Weisman MH., Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis. Arthritis Rheum 2008; 59: 822-32.
35. Haroon M, Winchester R, Giles JT, Heffernan E, FitzGerald O., Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype. Ann Rheum Dis 2016; 75: 155-62.